Bill
Bill > SB1495
TN SB1495
TN SB1495AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.
summary
Introduced
12/23/2025
12/23/2025
In Committee
Crossed Over
02/19/2026
02/19/2026
Passed
Dead
Introduced Session
114th General Assembly
Bill Summary
As introduced, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33.
AI Summary
This bill amends Tennessee Code Annotated, specifically sections 20-13-203 and 33-11-103(p), to add Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to a list of companies that may be released by the state's attorney general from pending or future legal claims related to opioids, alongside Purdue Pharma L.P. This action is part of ongoing efforts to address the opioid crisis, and the bill includes a severability clause, meaning if any part of the act is found invalid, the rest will still stand, and it takes effect immediately upon becoming law.
Committee Categories
Justice
Sponsors (1)
Last Action
Rcvd. from S., held on H. desk. (on 02/23/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=SB1495&ga=114 |
| Fiscal Note - SB1495 | https://www.capitol.tn.gov/Bills/114/Fiscal/SB1495.pdf |
| BillText | https://www.capitol.tn.gov/Bills/114/Bill/SB1495.pdf |
Loading...